Ataxia-Telangiectasia Guidelines

Updated: Jun 08, 2022
  • Author: Camila K Janniger, MD; Chief Editor: Dirk M Elston, MD  more...
  • Print


A team of experts, working within the LEGEND COST Action and Host Genomic Variation I-BFM Study Group, have put forth consensus recommendations for the clinical management of hematologic malignancies in patients with ataxia-telangiectasia (AT) and Nijmegen breakage syndrome (NBS). [7]